Polymorphic Associations and Structures of the Cross-Seeding of Aβ1-42 and hIAPP1-37 Polypeptides

Emerging evidence have shown that the patients with Alzheimer's disease (AD) often have a higher risk of later developing type II diabetes (T2D), and vice versa, suggesting a potential pathological link between AD and T2D. Amyloid-β (Aβ) and human islet amyloid polypeptide (hIAPP) are the principle causative components responsible for the pathologies of AD and T2D, respectively. The cross-sequence interactions between Aβ and hIAPP may provide a molecular basis for better understanding the potential link between AD and T2D. Herein, we systematically modeled and simulated the cross-sequence aggregation process, molecular interactions, and polymorphic structures of full-length Aβ and hIAPP peptides using a combination of coarse-grained (CG) replica-exchange molecular dynamics (REMD) and all-atom molecular dynamics (MD) simulations, with particular focus on the effect of association models between Aβ and hIAPP on the structural stability and polymorphic populations of hybrid Aβ-hIAPP aggregates. Four distinct association models (double-layer, elongation, tail-tail, and block models) between Aβ and hIAPP oligomers were identified, and the associated polymorphic Aβ-hIAPP structures were determined as well. Among them, different association models led to different Aβ-hIAPP aggregates, with large differences in structural morphologies and populations, interacting interfaces, and underlying association forces. The computational models support the cross-sequence interactions between Aβ and hIAPP pentamers, which would lead to the complex hybrid Aβ-hIAPP assemblies. This computational work may also provide a different point of view to a better understanding of a potential link between AD and T2D.

[1]  Rodrigo Morales,et al.  Molecular Cross Talk between Misfolded Proteins in Animal Models of Alzheimer's and Prion Diseases , 2010, The Journal of Neuroscience.

[2]  Tetsuaki Arai,et al.  Abeta and tau form soluble complexes that may promote self aggregation of both into the insoluble forms observed in Alzheimer's disease. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[3]  U Aebi,et al.  Polymorphic fibrillar assembly of human amylin. , 1997, Journal of structural biology.

[4]  R. Nussinov,et al.  Polymorphism in Alzheimer Aβ Amyloid Organization Reflects Conformational Selection in a Rugged Energy Landscape , 2010, Chemical reviews.

[5]  Ruth Nussinov,et al.  Synergistic Interactions between Repeats in Tau Protein and Aβ Amyloids May Be Responsible for Accelerated Aggregation via Polymorphic States , 2011, Biochemistry.

[6]  Ruth Nussinov,et al.  Conformational Basis for Asymmetric Seeding Barrier in Filaments of Three- and Four-Repeat Tau , 2012, Journal of the American Chemical Society.

[7]  Kunal Patel,et al.  De novo design of self-assembled hexapeptides as β-amyloid (Aβ) peptide inhibitors. , 2014, ACS chemical neuroscience.

[8]  Ruth Nussinov,et al.  Single mutations in tau modulate the populations of fibril conformers through seed selection. , 2014, Angewandte Chemie.

[9]  Ulrich H E Hansmann,et al.  In silico cross seeding of Aβ and amylin fibril-like oligomers. , 2013, ACS chemical neuroscience.

[10]  Yan Sun,et al.  Structural and energetic insight into the cross-seeding amyloid assemblies of human IAPP and rat IAPP. , 2014, The journal of physical chemistry. B.

[11]  M. Stefani,et al.  Biochemical and biophysical features of both oligomer/fibril and cell membrane in amyloid cytotoxicity , 2010, The FEBS journal.

[12]  H. Lashuel,et al.  Amyloidogenic protein-membrane interactions: mechanistic insight from model systems. , 2010, Angewandte Chemie.

[13]  D. Walsh,et al.  Protein Aggregation in the Brain: The Molecular Basis for Alzheimer’s and Parkinson’s Diseases , 2008, Molecular medicine.

[14]  Ayyalusamy Ramamoorthy,et al.  Membrane disruption and early events in the aggregation of the diabetes related peptide IAPP from a molecular perspective. , 2012, Accounts of chemical research.

[15]  Junjie Yao,et al.  Cross-seeding and cross-competition in mouse apolipoprotein A-II amyloid fibrils and protein A amyloid fibrils. , 2007, The American journal of pathology.

[16]  Ronald C Petersen,et al.  Increased risk of type 2 diabetes in Alzheimer disease. , 2004, Diabetes.

[17]  Andrea Caporale,et al.  Dissecting the Role of Single Regions of an IAPP Mimic and IAPP in Inhibition of Aβ40 Amyloid Formation and Cytotoxicity , 2011, Chembiochem : a European journal of chemical biology.

[18]  N. Mousseau,et al.  Replica exchange molecular dynamics simulations of coarse-grained proteins in implicit solvent. , 2009, The journal of physical chemistry. B.

[19]  Xavier Periole,et al.  Combining an Elastic Network With a Coarse-Grained Molecular Force Field: Structure, Dynamics, and Intermolecular Recognition. , 2009, Journal of chemical theory and computation.

[20]  B. Ahrén,et al.  Islet amyloid and type 2 diabetes mellitus. , 2000, The New England journal of medicine.

[21]  Ruth Nussinov,et al.  Molecular insights into the reversible formation of tau protein fibrils. , 2013, Chemical communications.

[22]  Catherine Klersy,et al.  Diabetes and Risk of Parkinson’s Disease , 2011, Diabetes Care.

[23]  Gerrit Groenhof,et al.  GROMACS: Fast, flexible, and free , 2005, J. Comput. Chem..

[24]  Alexander D. MacKerell,et al.  Importance of the CMAP correction to the CHARMM22 protein force field: dynamics of hen lysozyme. , 2006, Biophysical journal.

[25]  Kenjiro Ono,et al.  Structure–neurotoxicity relationships of amyloid β-protein oligomers , 2009, Proceedings of the National Academy of Sciences.

[26]  D. Selkoe,et al.  Natural oligomers of the amyloid-β protein specifically disrupt cognitive function , 2005, Nature Neuroscience.

[27]  Peter Marek,et al.  Two-dimensional infrared spectroscopy reveals the complex behavior of an amyloid fibril inhibitor , 2012, Nature chemistry.

[28]  Shiew-Mei Huang,et al.  The utility of modeling and simulation in drug development and regulatory review. , 2013, Journal of pharmaceutical sciences.

[29]  Ayyalusamy Ramamoorthy Insights into protein misfolding and amyloidogenesis. , 2013, Physical chemistry chemical physics : PCCP.

[30]  Bernard R Brooks,et al.  Modulation of Alzheimer's Aβ protofilament-membrane interactions by lipid headgroups. , 2015, ACS chemical neuroscience.

[31]  Roland Winter,et al.  Cross-amyloid interaction of Aβ and IAPP at lipid membranes. , 2012, Angewandte Chemie.

[32]  Jie Zheng,et al.  Polymorphic Structures of Alzheimer's β-Amyloid Globulomers , 2011, PloS one.

[33]  Peter Marek,et al.  Islet amyloid: From fundamental biophysics to mechanisms of cytotoxicity , 2012, FEBS letters.

[34]  Ruth Nussinov,et al.  Structural stability and dynamics of an amyloid-forming peptide GNNQQNY from the yeast prion sup-35. , 2006, Biophysical journal.

[35]  T. Rink,et al.  High affinity amylin binding sites in rat brain. , 1993, Molecular pharmacology.

[36]  Y. Miller,et al.  Orientations of residues along the β-arch of self-assembled amylin fibril-like structures lead to polymorphism. , 2015, Biomacromolecules.

[37]  Joan-Emma Shea,et al.  Structural Similarities and Differences between Amyloidogenic and Non-Amyloidogenic Islet Amyloid Polypeptide (IAPP) Sequences and Implications for the Dual Physiological and Pathological Activities of These Peptides , 2013, PLoS Comput. Biol..

[38]  A. Kapurniotu,et al.  Amyloidogenicity and cytotoxicity of islet amyloid polypeptide. , 2001, Biopolymers.

[39]  Kunal Patel,et al.  Cross-sequence interactions between human and rat islet amyloid polypeptides. , 2014, Langmuir : the ACS journal of surfaces and colloids.

[40]  Hong Qing,et al.  Beta amyloid and hyperphosphorylated tau deposits in the pancreas in type 2 diabetes , 2010, Neurobiology of Aging.

[41]  J. Richmond,et al.  Visualization of Aggregation of the Rnq1 Prion Domain and Cross-seeding Interactions with Sup35NM* , 2007, Journal of Biological Chemistry.

[42]  Ronald Wetzel,et al.  Seeding Specificity in Amyloid Growth Induced by Heterologous Fibrils* , 2004, Journal of Biological Chemistry.

[43]  Normand Mousseau,et al.  Distinct helix propensities and membrane interactions of human and rat IAPP(1-19) monomers in anionic lipid bilayers. , 2015, The journal of physical chemistry. B.

[44]  Jingdai Wang,et al.  Comparative molecular dynamics study of Abeta adsorption on the self-assembled monolayers. , 2010, Langmuir : the ACS journal of surfaces and colloids.

[45]  Guizhao Liang,et al.  Structural polymorphism of human islet amyloid polypeptide (hIAPP) oligomers highlights the importance of interfacial residue interactions. , 2011, Biomacromolecules.

[46]  R. Tycko,et al.  Experimental constraints on quaternary structure in Alzheimer's beta-amyloid fibrils. , 2006, Biochemistry.

[47]  T Lashley,et al.  Systemic Amyloid Deposits in Familial British Dementia* , 2001, The Journal of Biological Chemistry.

[48]  Jie Zheng,et al.  Non-selective ion channel activity of polymorphic human islet amyloid polypeptide (amylin) double channels. , 2014, Physical chemistry chemical physics : PCCP.

[49]  Ruth Nussinov,et al.  Selective molecular recognition in amyloid growth and transmission and cross-species barriers. , 2012, Journal of molecular biology.

[50]  P. May,et al.  Neurotoxicity of Human Amylin in Rat Primary Hippocampal Cultures: Similarity to Alzheimer's Disease Amyloid‐β Neurotoxicity , 1993, Journal of neurochemistry.

[51]  Richard Leapman,et al.  Peptide conformation and supramolecular organization in amylin fibrils: constraints from solid-state NMR. , 2007, Biochemistry.

[52]  Rolando Castillo,et al.  Multiscale molecular dynamics simulations of micelles: coarse-grain for self-assembly and atomic resolution for finer details† , 2012 .

[53]  Ruth Nussinov,et al.  Aβ(1–42) Fibril Structure Illuminates Self-recognition and Replication of Amyloid in Alzheimer’s , 2015, Nature Structural &Molecular Biology.

[54]  C. Reitz Alzheimer's Disease and the Amyloid Cascade Hypothesis: A Critical Review , 2012, International journal of Alzheimer's disease.

[55]  Brigita Urbanc,et al.  In silico study of amyloid β-protein folding and oligomerization , 2004 .

[56]  G Paxinos,et al.  In vitro autoradiographic localization of calcitonin and amylin binding sites in monkey brain , 2004, Journal of Chemical Neuroanatomy.

[57]  Petety V Balaji,et al.  Size, orientation and organization of oligomers that nucleate amyloid fibrils: clues from MD simulations of pre-formed aggregates. , 2012, Biochimica et biophysica acta.

[58]  Ruth Nussinov,et al.  Hollow core of Alzheimer’s Aβ42 amyloid observed by cryoEM is relevant at physiological pH , 2010, Proceedings of the National Academy of Sciences.

[59]  Kenjiro Ono,et al.  Cross‐seeding effects of amyloid β‐protein and α‐synuclein , 2012, Journal of neurochemistry.

[60]  Katsumi Matsuzaki,et al.  Cross‐seeding of wild‐type and hereditary variant‐type amyloid β‐proteins in the presence of gangliosides , 2005, Journal of neurochemistry.

[61]  M. Nicolls,et al.  The clinical and biological relationship between Type II diabetes mellitus and Alzheimer's disease. , 2004, Current Alzheimer research.

[62]  Joan-Emma Shea,et al.  Molecular Structures of Quiescently Grown and Brain-Derived Polymorphic Fibrils of the Alzheimer Amyloid Aβ9-40 Peptide: A Comparison to Agitated Fibrils , 2010, PLoS Comput. Biol..

[63]  Ulrich H E Hansmann,et al.  Mutations and seeding of amylin fibril-like oligomers. , 2013, The journal of physical chemistry. B.

[64]  W. Griffin,et al.  Inflammation and neurodegenerative diseases. , 2006, The American journal of clinical nutrition.

[65]  N. Buchete,et al.  Amyloid β Protein and Alzheimer's Disease: When Computer Simulations Complement Experimental Studies. , 2015, Chemical reviews.

[66]  F. Sundler,et al.  Islet amyloid polypeptide (amylin) is expressed in sensory neurons , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[67]  Ruth Nussinov,et al.  Cross-seeding and Conformational Selection between Three- and Four-repeat Human Tau Proteins , 2012, The Journal of Biological Chemistry.

[68]  P. Butler,et al.  Islet amyloid in type 2 diabetes, and the toxic oligomer hypothesis. , 2008, Endocrine reviews.

[69]  Guizhao Liang,et al.  Comparative molecular dynamics study of human islet amyloid polypeptide (IAPP) and rat IAPP oligomers. , 2013, Biochemistry.

[70]  Jingdai Wang,et al.  Molecular modeling of two distinct triangular oligomers in amyloid beta-protein. , 2010, The journal of physical chemistry. B.

[71]  Michel Goedert,et al.  Alpha-synuclein and neurodegenerative diseases , 2001, Nature Reviews Neuroscience.

[72]  Ronald Frank,et al.  Identification of hot regions of the Abeta-IAPP interaction interface as high-affinity binding sites in both cross- and self-association. , 2010, Angewandte Chemie.

[73]  R. Atwal,et al.  Huntington’s disease: revisiting the aggregation hypothesis in polyglutamine neurodegenerative diseases , 2008, The FEBS journal.

[74]  R. Riek,et al.  3D structure of Alzheimer's amyloid-β(1–42) fibrils , 2005 .

[75]  R. Nussinov,et al.  Polymorphism of Alzheimer's Abeta17-42 (p3) oligomers: the importance of the turn location and its conformation. , 2009, Biophysical journal.

[76]  Ulrich H E Hansmann,et al.  Stability of Iowa mutant and wild type Aβ-peptide aggregates. , 2014, The Journal of chemical physics.

[77]  Richard D. Leapman,et al.  Molecular structural basis for polymorphism in Alzheimer's β-amyloid fibrils , 2008, Proceedings of the National Academy of Sciences.

[78]  Mingzhen Zhang,et al.  Molecular understanding of a potential functional link between antimicrobial and amyloid peptides. , 2014, Soft matter.

[79]  Judianne Davis,et al.  Structural conversion of neurotoxic amyloid-β(1–42) oligomers to fibrils , 2010, Nature Structural &Molecular Biology.

[80]  Jie Zheng,et al.  Interfacial interaction and lateral association of cross-seeding assemblies between hIAPP and rIAPP oligomers. , 2015, Physical chemistry chemical physics : PCCP.

[81]  Norbert Opitz,et al.  Interaction of hIAPP with Model Raft Membranes and Pancreatic β‐Cells: Cytotoxicity of hIAPP Oligomers , 2010, Chembiochem : a European journal of chemical biology.

[82]  Ruth Nussinov,et al.  Conformational distribution and α-helix to β-sheet transition of human amylin fragment dimer. , 2014, Biomacromolecules.

[83]  W F Drew Bennett,et al.  Improved Parameters for the Martini Coarse-Grained Protein Force Field. , 2013, Journal of chemical theory and computation.

[84]  Thomas L. Williams,et al.  Membrane and surface interactions of Alzheimer’s Aβ peptide – insights into the mechanism of cytotoxicity , 2011, The FEBS journal.

[85]  Ulrich H. E. Hansmann,et al.  Inter-Species Cross-Seeding: Stability and Assembly of Rat - Human Amylin Aggregates , 2014, PloS one.

[86]  Ruth Nussinov,et al.  Alzheimer Aβ Amyloid Annular Fibrils: Insight Into Polymorphism , 2011 .

[87]  M. Stefani,et al.  Structural features and cytotoxicity of amyloid oligomers: Implications in Alzheimer's disease and other diseases with amyloid deposits , 2012, Progress in Neurobiology.